[1] |
Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract, 2022; 183, 109119. doi: 10.1016/j.diabres.2021.109119 |
[2] |
Yang L, Ma JF, Zhang XL, et al. Protective role of the vitamin D receptor. Cell Immunol, 2012; 279, 160−6. doi: 10.1016/j.cellimm.2012.10.002 |
[3] |
American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care, 2008; 31 Suppl 1, S61−78. |
[4] |
Han JC, Du J, Zhang YJ, et al. Vitamin D receptor polymorphisms may contribute to asthma risk. J Asthma, 2016; 53, 790−800. doi: 10.3109/02770903.2016.1158267 |
[5] |
Saccone D, Asani F, Bornman L. Regulation of the vitamin D receptor gene by environment, genetics and epigenetics. Gene, 2015; 561, 171−80. doi: 10.1016/j.gene.2015.02.024 |
[6] |
Zeitz U, Weber K, Soegiarto DW, et al. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J, 2003; 17, 509−11. |
[7] |
Ogunkolade BW, Boucher BJ, Prahl JM, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes, 2002; 51, 2294−300. doi: 10.2337/diabetes.51.7.2294 |
[8] |
Kamei Y, Kawada T, Kazuki R, et al. Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. Biochem Biophys Res Commun, 1993; 193, 948−55. doi: 10.1006/bbrc.1993.1717 |
[9] |
Vasilopoulos Y, Sarafidou T, Kotsa K, et al. VDR TaqI is associated with obesity in the Greek population. Gene, 2013; 512, 237−9. doi: 10.1016/j.gene.2012.10.044 |
[10] |
Burton GR, Guan Y, Nagarajan R, et al. Microarray analysis of gene expression during early adipocyte differentiation. Gene, 2002; 293, 21−31. doi: 10.1016/S0378-1119(02)00726-6 |